Nextage Therapeutics (Israel) Price Prediction

MCTC Stock  ILA 37.70  1.30  3.33%   
At this time, the value of RSI of Nextage Therapeutics' share price is approaching 47. This indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Nextage Therapeutics' stock, making its price go up or down.

Oversold Vs Overbought

47

 
Oversold
 
Overbought
Nextage Therapeutics stock price prediction is an act of determining the future value of Nextage Therapeutics shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Nextage Therapeutics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Nextage Therapeutics and does not consider all of the tangible or intangible factors available from Nextage Therapeutics' fundamental data. We analyze noise-free headlines and recent hype associated with Nextage Therapeutics, which may create opportunities for some arbitrage if properly timed.
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Nextage Therapeutics based on different types of headlines from major news networks to social media. The Nextage stock price prediction module provides an analysis of price elasticity to changes in media outlook on Nextage Therapeutics over a specific investment horizon. Using Nextage Therapeutics hype-based prediction, you can estimate the value of Nextage Therapeutics from the perspective of Nextage Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Nextage Therapeutics. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Nextage Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Nextage because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Nextage Therapeutics after-hype prediction price

    
  ILA 37.7  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Nextage Therapeutics Basic Forecasting Models to cross-verify your projections.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Nextage Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Nextage Therapeutics in the context of predictive analytics.
Intrinsic
Valuation
LowRealHigh
25.6831.4241.47
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Nextage Therapeutics. Your research has to be compared to or analyzed against Nextage Therapeutics' peers to derive any actionable benefits. When done correctly, Nextage Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Nextage Therapeutics.

Nextage Therapeutics After-Hype Price Prediction Density Analysis

As far as predicting the price of Nextage Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Nextage Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Nextage Therapeutics, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Nextage Therapeutics Estimiated After-Hype Price Volatility

In the context of predicting Nextage Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Nextage Therapeutics' historical news coverage. Nextage Therapeutics' after-hype downside and upside margins for the prediction period are 31.96 and 43.44, respectively. We have considered Nextage Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
37.70
37.70
After-hype Price
43.44
Upside
Nextage Therapeutics is not too volatile at this time. Analysis and calculation of next after-hype price of Nextage Therapeutics is based on 3 months time horizon.

Nextage Therapeutics Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Nextage Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Nextage Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Nextage Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.38 
5.74
 0.00  
 0.00  
0 Events / Month
0 Events / Month
Uncertain
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
37.70
37.70
0.00 
0.00  
Notes

Nextage Therapeutics Hype Timeline

Nextage Therapeutics is now traded for 37.70on Tel Aviv Stock Exchange of Israel. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Nextage estimated not to react to the next headline with the price going to stay at about the same level and average media hype impact volatility of insignificant. The immediate return on the next newsis estimated to be very small whereas the daily expected return is now at 0.38%. The volatility of relative hype elasticity to Nextage Therapeutics is about 0.0%. The volatility of related hype on Nextage Therapeutics is about 0.0% with expected price after next announcement by competition of 37.7. About 22.0% of the company outstanding shares are owned by corporate insiders. The book value of Nextage Therapeutics was now reported as 0.9. The company recorded a loss per share of 0.24. Nextage Therapeutics last dividend was issued on the 9th of June 2003. The entity had 1:20 split on the 12th of April 2020. Assuming the 90 days trading horizon the next estimated press release will be uncertain.
Check out Nextage Therapeutics Basic Forecasting Models to cross-verify your projections.

Nextage Therapeutics Related Hype Analysis

Having access to credible news sources related to Nextage Therapeutics' direct competition is more important than ever and may enhance your ability to predict Nextage Therapeutics' future price movements. Getting to know how Nextage Therapeutics rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Nextage Therapeutics may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
LUMIBank Leumi Le Israel 0.00 0 per month 1.27 (0.03) 2.91 (1.94) 6.70 
MZTFMizrahi Tefahot 0.00 0 per month 0.00 (0.08) 4.01 (2.68) 11.57 
NSTRNorstar 0.00 0 per month 2.57  0.02  6.27 (4.17) 21.16 
GZTGazit Globe 0.00 0 per month 0.00 (0.05) 6.06 (4.38) 15.12 
ALHEAlony Hetz Properties 0.00 0 per month 2.47 (0.01) 4.97 (4.30) 15.50 
DLEKGDelek Group 0.00 0 per month 1.57 (0.05) 4.18 (2.49) 12.43 
AZRGAzrieli Group 0.00 0 per month 1.22  0.13  4.93 (2.47) 9.40 
BIGBig Shopping Centers 0.00 0 per month 1.28  0.08  5.09 (2.38) 9.26 
DSCTIsrael Discount Bank 0.00 0 per month 0.00 (0.11) 2.85 (2.18) 9.18 

Nextage Therapeutics Additional Predictive Modules

Most predictive techniques to examine Nextage price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Nextage using various technical indicators. When you analyze Nextage charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Nextage Therapeutics Predictive Indicators

The successful prediction of Nextage Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Nextage Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Nextage Therapeutics based on analysis of Nextage Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Nextage Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Nextage Therapeutics's related companies.

Story Coverage note for Nextage Therapeutics

The number of cover stories for Nextage Therapeutics depends on current market conditions and Nextage Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Nextage Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Nextage Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Nextage Therapeutics Short Properties

Nextage Therapeutics' future price predictability will typically decrease when Nextage Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Nextage Therapeutics often depends not only on the future outlook of the potential Nextage Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Nextage Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Shares Float217.3 K
Check out Nextage Therapeutics Basic Forecasting Models to cross-verify your projections.
You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Complementary Tools for Nextage Stock analysis

When running Nextage Therapeutics' price analysis, check to measure Nextage Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nextage Therapeutics is operating at the current time. Most of Nextage Therapeutics' value examination focuses on studying past and present price action to predict the probability of Nextage Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nextage Therapeutics' price. Additionally, you may evaluate how the addition of Nextage Therapeutics to your portfolios can decrease your overall portfolio volatility.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Stocks Directory
Find actively traded stocks across global markets
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Global Correlations
Find global opportunities by holding instruments from different markets
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Please note, there is a significant difference between Nextage Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nextage Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nextage Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.